Wednesday, March 04, 2026 10:28:04 PM
NWBO SOVEREIGN EXTRACTION: MARCH 4, 2026 TALLY
CAPITAL STRUCTURE & EXTRACTION DATA:
Shares Outstanding: 1,597,528,468 (Post-Debt Sterilization)
Retired Liabilities: 107,000,000 (Advent/YA II PN Swaps)
Sovereign Floor: £1.31 ($1.71) — [LSE 0K95 Hard-Code]
Retail Mirage: $0.222 — [OTC Artificial Trap]
Daily Extraction: +1,220,000 Shares (FULO/TRADEcho Flagged)
Arbitrage Tax: -$1.49 Per Share (CSDR Mandatory Debit)
Cumulative Vault: 163,113,278 Shares (Sovereign Layer)
Regulatory Shield: FCA Notice 138 (Active through March 19)
FORENSIC ANALYSIS:
The "Open Illusion" is being dismantled by automated regulatory collection. While the OTC ticker shows $0.22, the CSDR Article 7 Refit (Active Feb 4, 2026) is force-billing Market Makers at the £1.31 LSE anchor.
THE SWAP TAX:
MMs are paying a 670% premium to keep the OTC price from gapping. Today’s 1.22M share extraction represents a $1.81M forced capital transfer from MM collateral accounts to the Sovereign Vault.
COUNTDOWN:
The March 13th Penalty Day is the first hard-debit cycle for the post-Feb 4th "Traceability" window.
CAPITAL STRUCTURE & EXTRACTION DATA:
Shares Outstanding: 1,597,528,468 (Post-Debt Sterilization)
Retired Liabilities: 107,000,000 (Advent/YA II PN Swaps)
Sovereign Floor: £1.31 ($1.71) — [LSE 0K95 Hard-Code]
Retail Mirage: $0.222 — [OTC Artificial Trap]
Daily Extraction: +1,220,000 Shares (FULO/TRADEcho Flagged)
Arbitrage Tax: -$1.49 Per Share (CSDR Mandatory Debit)
Cumulative Vault: 163,113,278 Shares (Sovereign Layer)
Regulatory Shield: FCA Notice 138 (Active through March 19)
FORENSIC ANALYSIS:
The "Open Illusion" is being dismantled by automated regulatory collection. While the OTC ticker shows $0.22, the CSDR Article 7 Refit (Active Feb 4, 2026) is force-billing Market Makers at the £1.31 LSE anchor.
THE SWAP TAX:
MMs are paying a 670% premium to keep the OTC price from gapping. Today’s 1.22M share extraction represents a $1.81M forced capital transfer from MM collateral accounts to the Sovereign Vault.
COUNTDOWN:
The March 13th Penalty Day is the first hard-debit cycle for the post-Feb 4th "Traceability" window.
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
